Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review

<table>(a) Neoplastic cells demonstrating strong CD3 positivity (200x magnification), (b) neoplastic T cells with aberrant CD20 positivity (100x magnification), and (c) neoplastic T cells with aberrant CD79a positivity (100x magnification).</table>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review 